CN1171615C - Chinese medicine prepn for treating fatty liver and obesity - Google Patents

Chinese medicine prepn for treating fatty liver and obesity Download PDF

Info

Publication number
CN1171615C
CN1171615C CNB021255210A CN02125521A CN1171615C CN 1171615 C CN1171615 C CN 1171615C CN B021255210 A CNB021255210 A CN B021255210A CN 02125521 A CN02125521 A CN 02125521A CN 1171615 C CN1171615 C CN 1171615C
Authority
CN
China
Prior art keywords
rhizoma
rhizoma atractylodis
fatty liver
preparation
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB021255210A
Other languages
Chinese (zh)
Other versions
CN1398615A (en
Inventor
崔兴中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB021255210A priority Critical patent/CN1171615C/en
Publication of CN1398615A publication Critical patent/CN1398615A/en
Application granted granted Critical
Publication of CN1171615C publication Critical patent/CN1171615C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The present invention relates to a traditional Chinese medicine preparation for treating fatty liver and adiposis, which is characterized in that the present invention is composed of the components with the weight ratio of 3 to 5 of atractylodes rhizome, 3 to 5 of white atractylodes rhizome, 3 to 5 of magnolia bark, 3 to 5 of fructus aurantii, 3 to 5 of orange peel, 2 to 4 of rhizoma pinelliae, 3 to 5 platycodon roots, 2 to 4 of white mustard seeds, 4 to 5 of rdish seeds, 3 to 5 of rhubarb, 4 to 5 of water plantain and 4 to 5 of haws. The preparation of the present invention, which is the components of natural plants, has the advantages of conspicuous treating effect, no return, no irritation to stomach intestine gastrointestinal tracts and low cost.

Description

A kind of Chinese medicine preparation for the treatment of fatty liver and obesity and preparation method thereof
Technical field
The present invention relates to a kind of Chinese medicine preparation, particularly a kind of Chinese medicine preparation for the treatment of fatty liver and obesity and preparation method thereof.
Background technology
Along with deepening continuously of reform and opening-up, people's material life is greatly improved, and the structure content of clothing, food, lodging and transportion--basic necessities of life all changes thereupon, and spectrum of disease is also corresponding and change.So-called affluenza takes place thereupon, and for example the sickness rate of obesity, merging cardiovascular and cerebrovascular disease, hypertension, coronary heart disease, cerebrovascular accident, diabetes, fatty liver etc. significantly rises, and people's health and lives in serious threat.At present, because the good treatment of life, the too much absorption of nutrition and the obese fatty liver disease that causes has become one of unhealthful frequently-occurring disease, commonly encountered diseases, the common method of treatment of obesity has the weight-reducing by dieting method, the weight reduction with drugs method, the weight-reducing by dieting method is generally with the low heat value food meal, or the feed of semistarvation state, loses weight with the description and quantity that limits feed.Owing to limited feed, do not guarantee normal nutritional need, can make weak, the anorexia of people, health is affected, and also can rebound after the fat-reducing.Existing Drug therapy fatty liver person also can limit feed to a certain extent.The active drug of treatment fatty liver is few, and effect is not satisfactory, and Western medicine is chemically made, the more complicated price height of technology, and often take and can stimulation be arranged to stomach.
Content of the present invention
The purpose of this invention is to provide a kind of Chinese medicine preparation for the treatment of fatty liver and obesity and preparation method thereof, said preparation has evident in efficacy, does not rebound, and is non-stimulated to gastrointestinal, the advantage that price is low.
The objective of the invention is to realize by following technical scheme.A kind of Chinese medicine preparation for the treatment of fatty liver and obesity of the present invention is characterized in that it is made by weight proportion by following raw material:
Rhizoma Atractylodis 3-5 Rhizoma Atractylodis Macrocephalae 3-5 Cortex Magnoliae Officinalis 3-5
Fructus Aurantii 3-5 Pericarpium Citri Reticulatae 3-5 Rhizoma Pinelliae 2-4
Radix Platycodonis 3-5 Semen Sinapis Albae 2-4 Semen Raphani 4-5
Radix Et Rhizoma Rhei 3-5 Rhizoma Alismatis 4-5 Fructus Crataegi 4-5
Its method for production comprises following step preface:
(1) get the raw materials ready, each raw material got all the ready by prescription,
(2) pulverize, Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae, Rhizoma Alismatis pulverized, sieve,
(3) decocting and concentrating, all the other raw material waters decoct in will filling a prescription, and decoct successively 3 hours, and medicinal liquid is taken out; Add water again medical material was decocted 2 hours, medicinal liquid is taken out; Add water again medical material was decocted 1 hour, medicinal liquid is taken out; The medicinal liquid of above-mentioned three decoctions is mixed, be condensed into fluid extract;
(4) mix, above-mentioned Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae, the Rhizoma Alismatis powder that adds above-mentioned pulverizing in the fluid extract, the mixing of being condensed into;
(5) drying and crushing is with each raw material drying of mixing and be ground into fine powder, mixing again;
(6) preparation is made preparation with above-mentioned fine powder.
Theory of Chinese medical science thinks that the origin cause of formation of obese fatty liver disease is mainly nutrition and crosses and contain (though fatty liver also may because chronic alcoholism, diabetic supersession are unusual, hepatitis causes) in the majority.Fatty liver and obesity are common in polyphagia delicious food on ordinary days, and after the people that physical exertion is less, particularly middle age, spleen fortuneization function day by day goes down, if more double eating and drinking without temperance, be disinclined to activity, temper is not transported, then the paddy food can not turn to and precise and tiny gathering form phlegm-damp, and interior work causes the irritability catharsis in body.Jin Dynasty well-known doctor Li Dongyuan calls splenogastric asthenia, obesity with poor appetite, though fertilizer and inability to raise the limbs, this is as the tired drowsy and lazy moving disease of the fat people Chang Yi of clinical findings fat.Many obese patients often tell that diet is controlled and body fertilizer does not still subtract, also above-mentioned just so.The people of obesity merges the fatty liver, and the person is a lot, but the lighter's non-evident sympton is more if liver fat stockpiles, and can feel diseases such as right side of body rib hepatic region distension or pain and abdominal distention is tired.The traditional Chinese medical science is thought insufficiency of the spleen phlegm resistance, irritability imbalance so, phlegm-damp disappears certainly if spleen can be good for transport then, irritability also can freely be transferred.The applicant makes this Chinese medicine preparation according to above-mentioned theory of Chinese medical science.In the Chinese medicine preparation of the present invention, adopt spleen invigorating to help fortune wet the stagnant method of removing food stagnancy of reducing phlegm, the employing Rhizoma Pinelliae, Pericarpium Citri Reticulatae, Radix Platycodonis, Semen Sinapis Albae are wet to reduce phlegm; Adopt Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae with spleen invigorating; Cortex Magnoliae Officinalis, Fructus Aurantii, Semen Raphani expand to remove; Rhizoma Alismatis is with dampness removing; Fructus Crataegi, Radix Et Rhizoma Rhei amass to remove; And Rhizoma Alismatis, Fructus Crataegi also have the effect of blood fat reducing.
In sum, the reason that the present invention is directed to the generation of obese fatty liver disease is suited the remedy to the case, and is remarkable through clinical result of use, do not rebound.Also can treat hyperlipidemia.This preparation medicine source is a natural plants, and its technology simpler production price is low, takes gastrointestinal is had no adverse reaction.
Embodiment 1 capsule
The present invention once carried out clinical practice with the sharp capsule for protecting liver of preparation fat eliminating by name, and effect is remarkable.
Prescription: by the part by weight preparation of following raw material
Rhizoma Atractylodis 4 Rhizoma Atractylodis Macrocephalaes 4 Cortex Magnoliae Officinalis 4
Fructus Aurantii 4 Pericarpium Citri Reticulataes 4 Rhizoma Pinelliaes 3
Radix Platycodonis 4 Semen Sinapis Albaes 3 Semen Raphanis 5
Radix Et Rhizoma Rhei 4 Rhizoma Alismatis 5 Fructus Crataegis 5
Method for production comprises following step preface:
(1) get the raw materials ready, each raw medicinal material selected, after the roguing, cleaning, drying, by formula proportion each raw material got all the ready,
(2) pulverize, Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae, Rhizoma Alismatis pulverized, cross 100 mesh sieves,
(3) decocting and concentrating, all the other raw material waters decoct in will filling a prescription, decoct 3 hours successively after, medicinal liquid is taken out; Decoct with water 2 hours again, medicinal liquid is taken out; Decoct with water 1 hour again, medicinal liquid is taken out; Decoct the medicinal liquid that produces with above-mentioned three times and mix, be condensed into fluid extract;
(4) mix, the above-mentioned Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae, the Rhizoma Alismatis powder that are condensed into the above-mentioned pulverizing of adding in the fluid extract, mixing;
(5) drying and crushing with each raw material drying of above-mentioned mixing, and is ground into fine powder, mixing again;
(6) preparation incapsulates into capsule preparations with above-mentioned fine powder.
Embodiment 2 tablets
Prescription: with the prescription of embodiment 1.
Method for production:
(1), (2), (3) (4), (5) are all with the corresponding step preface of embodiment 1.
(6) preparation with above-mentioned fine powder and excipient fusion, is pressed into tablet with tablet machine.
The present invention once with the sharp capsule for protecting liver of fat eliminating be the clinical practice of preparation name in treatment fatty liver, obesity, its effect is remarkable, has spleen invigorating and helps fortune, the wet removing food stagnancy that the reduces phlegm effect that stagnates.Clinical practice improves right distending pain over the hypochondrium, abdominal distention, weak symptom significantly in treatment fatty liver and obesity 368 examples, the 2-4 kilogram of losing weight per course of treatment, and 1/3rd patient through the color ultrasound check, recovers normal after the treatment of 1-3 the course of treatment mostly.Most patient symptoms disappear, and weight loss meets the clinical cure condition.In 368 patients, nearly 1/5th people took existing lipid lowerers DB GANTAI PIAN, liver-protecting tablet and other Chinese patent medicine 2 in advance and did not improve symptom by 3 months or 5 to 8 months.It is remarkable to take the sharp capsule for protecting liver effect of fat eliminating of the present invention, as following table:
The sharp capsule for protecting liver curative effect of fat eliminating statistical table
The efficacy assessment standard of foundation (by slight person 1-2 course of treatment, moderate person 2-3 course of treatment, the severe person 3-4 effect of the course of treatment, be 2 months per course of treatment):
Cure: cardinal symptom disappears, and hepatomegaly disappears or retraction, and the hepatic region does not have obvious tenderness or percussion pain, and liver function is normal, and ultrasonic echo figure and ultrasonogram are normal, and blood fat is tending towards normal or obviously improves weight loss.
Take a turn for the better: cardinal symptom disappears substantially, and hepatomegaly is recovered to some extent, and ultrasonoscopy is clearly better, and blood fat makes moderate progress, and body weight descends to some extent.
Invalid: symptom, sign, chemical examination, ultrasonoscopy and body weight do not have the changer.
Preparation of the present invention has the obvious patient's of improvement the weak effect of right distending pain over the hypochondrium, abdominal distention, and has the effect that Weight-reducing and lipid-lowering improves liver function through clinical practice.By medicine of the present invention as can be seen in the table, curing number in 368 examples is 266 examples, and its cure rate is 72%, and good revolution is 94 examples, accounts for 26%, and invalid is 8 examples, accounts for 2%, and total effective rate is 98%.Have no adverse reaction in taking.

Claims (2)

1, a kind of Chinese medicine preparation for the treatment of fatty liver and obesity is characterized in that it is made by weight proportion by following raw material:
Rhizoma Atractylodis 3-5 Rhizoma Atractylodis Macrocephalae 3-5 Cortex Magnoliae Officinalis 3-5
Fructus Aurantii 3-5 Pericarpium Citri Reticulatae 3-5 Rhizoma Pinelliae 2-4
Radix Platycodonis 3-5 Semen Sinapis Albae 2-4 Semen Raphani 4-5
Radix Et Rhizoma Rhei 3-5 Rhizoma Alismatis 4-5 Fructus Crataegi 4-5
2, a kind of method for production for the treatment of the Chinese medicine preparation of fatty liver and obesity according to claim 1 is characterized in that comprising following step preface:
(1) get the raw materials ready, each raw material got all the ready by prescription,
(2) pulverize, Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae, Rhizoma Alismatis pulverized, sieve,
(3) decocting and concentrating, all the other raw material waters decoct in will filling a prescription, and decoct successively 3 hours, and medicinal liquid is taken out; Add water again medical material was decocted 2 hours, medicinal liquid is taken out; Add water again medical material was decocted 1 hour, medicinal liquid is taken out; The medicinal liquid of above-mentioned three decoctions is mixed, be condensed into fluid extract;
(4) mix, above-mentioned Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae, the Rhizoma Alismatis powder that adds above-mentioned pulverizing in the fluid extract, the mixing of being condensed into;
(5) drying and crushing is with each raw material drying of mixing and be ground into fine powder, mixing again;
(6) preparation is made preparation with above-mentioned fine powder.
CNB021255210A 2002-07-17 2002-07-17 Chinese medicine prepn for treating fatty liver and obesity Expired - Fee Related CN1171615C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB021255210A CN1171615C (en) 2002-07-17 2002-07-17 Chinese medicine prepn for treating fatty liver and obesity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB021255210A CN1171615C (en) 2002-07-17 2002-07-17 Chinese medicine prepn for treating fatty liver and obesity

Publications (2)

Publication Number Publication Date
CN1398615A CN1398615A (en) 2003-02-26
CN1171615C true CN1171615C (en) 2004-10-20

Family

ID=4745580

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB021255210A Expired - Fee Related CN1171615C (en) 2002-07-17 2002-07-17 Chinese medicine prepn for treating fatty liver and obesity

Country Status (1)

Country Link
CN (1) CN1171615C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101417058B (en) * 2008-12-10 2011-04-27 逯传玲 Traditional Chinese medicine combination for treating obesity

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100444868C (en) * 2004-11-04 2008-12-24 苗毅韧 Weight-reducing Chinese medicinal formulation and preparation process thereof
CN101401918B (en) * 2008-11-06 2011-06-01 韩海林 Chinese medicinal composition for treating fatty liver
CN101417056B (en) * 2008-12-09 2011-01-12 赵玉红 Traditional Chinese medicine decoction for treating obesity
CN102698225A (en) * 2012-05-31 2012-10-03 李新欣 Chinese medicine for treating postpartum paroxysmal obesity
CN109331104A (en) * 2018-11-09 2019-02-15 南宁学院 A kind of drug and preparation method thereof for treating obesity
CN111228422B (en) * 2020-04-01 2021-09-17 嘉应学院 Traditional Chinese medicine composition for reducing intramuscular fat of chicken and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101417058B (en) * 2008-12-10 2011-04-27 逯传玲 Traditional Chinese medicine combination for treating obesity

Also Published As

Publication number Publication date
CN1398615A (en) 2003-02-26

Similar Documents

Publication Publication Date Title
CN1132643A (en) Medicine for diseases of liver and gall
CN1245883C (en) Slim tea
CN1486740A (en) Chinese medicine composition for treating cancer
CN1171615C (en) Chinese medicine prepn for treating fatty liver and obesity
CN1110924A (en) Effective drug for gastric disease
CN1823995A (en) New medicine for treating malignant tumour
CN1218721C (en) Chinese medicine proprietary for treating cerebrovascular and cardiovascular disease
CN100334972C (en) Body building health preparation and its producing method
CN1879783A (en) A medicine for treating diabetes
CN1050292C (en) Anticancer drug and preparing method thereof
CN1109553C (en) Chinese-medicinal capsule for treating diabetes
CN1611232A (en) Medicinal composition with main effect of antifatigue, radioresistance and melancholia-resistance and its preparing method
CN1064548C (en) Capsule for promoting male sexual function and preparation process
CN1253196C (en) Medicine for treating colitis
CN1483422A (en) Medicine for treating diabetes
CN1285367C (en) Medicinal preparation for treating diabetes and its preparation method
CN1217204A (en) Medicine for nourishing muscle and recovering physical strength, and preparation method therefor
CN1059333C (en) Chinese patent drug for various cancers and tumors
CN1269493C (en) Medicine for treating fatigue syndrome and preventing presenility, and preparation method thereof
CN1086129C (en) Hepatitis restoration pill
CN103933282A (en) Traditional Chinese medicine preparation for treating diabetes
CN108542946B (en) Traditional Chinese medicine prescription with weight-losing function and preparation method thereof
CN1247251C (en) Hyperlipemia treating medicine
CN101032613B (en) Hepatic cyst-treating Chinese traditional medicine preparation and its preparation process
CN1813876A (en) Xian Pengliaofu oral preparation-a Chinese medicine for treating bone disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
DD01 Delivery of document by public notice

Addressee: Cui Xingzhong

Document name: Notification of Termination of Patent Right

DD01 Delivery of document by public notice
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20041020

Termination date: 20180717

CF01 Termination of patent right due to non-payment of annual fee